Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Sales | 0 | 1 | 1 | -5 | 9 |
| Cost of Goods | 0 | 0 | 0 | 6 | 0 |
| Gross Profit | 0 | 1 | 1 | -10 | 8 |
| Operating Expenses | 49 | 23 | 27 | -36 | 85 |
| Operating Income | -49 | -22 | -26 | 31 | -76 |
| Interest Expense | 42 | 37 | 38 | -31 | 103 |
| Other Income | 3 | 49 | 0 | -30 | 55 |
| Pre-tax Income | -88 | -10 | -63 | 31 | -125 |
| Net Income Continuous | -88 | -10 | -63 | 31 | -125 |
| Net Income | $-88 | $-10 | $-63 | $31 | $-125 |
| EPS Basic Total Ops | -12.99 | 0.00 | -6.49 | N/A | -12.99 |
| EPS Basic Continuous Ops | -10.84 | -1.25 | -7.78 | 3.68 | -15.37 |
| EPS Diluted Total Ops | -12.99 | 0.00 | -6.49 | N/A | -12.99 |
| EPS Diluted Continuous Ops | -10.84 | -1.25 | -7.78 | 3.68 | -15.37 |
| EBITDA(a) | $-44 | $-22 | $-26 | $30 | $-76 |